300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Alpenroute Asset Management, VC Fund

Alpenroute Asset Management

VC Fund

Seoul, South Korea

Alpenroute Asset Management is a VC fund in Seoul focused on Medical and Health Care. Alpenroute Asset Management pursues capturing the root of companies’ values and invest at a lower price. Through its accumulated data analysis, the company enables to realize excellent return regardless of the market situation.Utilizing that system, Alpenroute studies where to invest, which industry to pay attention to, and which company wouldmanifest value.

Total investments:
7
Last investment:
Lead investor:
0%

Last updated:

Industries Alpenroute Asset Management invests in

MedicalHealth CareBiotechnologyEdTechGaming

Stages Alpenroute Asset Management invests in

Funding RoundSeries BSeries ASeries C

Countries Alpenroute Asset Management invests in

South Korea

Contacts

NameEmailPhoneSocials
Hang-Ki Kim Hang-Ki Kim

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 2 (29%)
  • Health Care 2 (29%)
  • Biotechnology 2 (29%)
  • EdTech 1 (14%)
  • Gaming 1 (14%)
See all 19 industries →

Stage

  • Funding Round 3 (43%)
  • Series B 2 (29%)
  • Series A 1 (14%)
  • Series C 1 (14%)

Team

NameTitleInvestmentsLinksEmail
Hang-Ki Kim
Hang-Ki Kim CEO& Head of Fund Management
CEO& Head of Fund Management Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Bilix Bilix
Bilix is a biotechnology company that produces anti-inflammatory and cancer therapy drugs for inflammatory diseases. Bilix, developer of PEGylated bilirubin nanoparticles designed to treat ischemia-reperfusion injury by reducing inflammation and oxidative stress. Series B / Jul 17, 2025
Hodoo English Hodoo English
Hodoo English is a quest-based MMORPG with built-in speech recognition and over 300 non-player characters with whom the player must have meaningful conversations in English. The game was designed by videogame giant NCSOFT to address "mute English", a pedagogical problem in which a school system produces students who can read and write inEnglish but cannot speak it.In Hodoo English, learners are immersed in a rich 3D world where they complete quests and interact with different characters by speaking English. Your child is the main character of the story, using his or her growing English vocabulary in a variety of situations. $7.8M / Series A / Oct 06, 2020
Logispot Logispot
Logispot provides digital logistics and freight transport services. Their platform provides convenient and systematic functions including integrated transport management, incoming and outgoing management, and interlocking with customers' internal systems, enabling customers to have hassle-free transportation of goods and services.The companywas founded in 2016 and is based in Seoul, South Korea. $7.4M / Series B / Oct 22, 2019
Riiid Riiid
Riiid is a global leading AI Tutor solution provider delivering creative disruption to the education market through its cutting-edge AI technology. The firm’s first commercialized AI Tutor solution, based on a deep learning algorithm which has garnered 1 million users solely in the Korean market with proven efficacy. Leveraging the firm’s highlyscalable and proven AI solution, Rigid is expanding its business to new test areas as well as into new geographical markets and rapid fashion. $14.9M / Series C / Jul 15, 2019
ViGenCell ViGenCell
ViGenCell is a medical company that specializes in immune cell therapy. Jan 01, 2019
Immunabs Immunabs
ImmunAbs specialize in antibody therapeutics in global standard development. The company develops antibody therapeutics for orphan diseases, diabetic retinopathy, and diabetes based on its experience developing antibody therapeutics that have been globally approved for sale in the United States and Europe. Jan 01, 2019
NDREAM NDREAM
NDREAM is a mobile game and software development company. $38.3M / Jun 14, 2018

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Alpenroute Asset Management invest in?

Alpenroute Asset Management invests primarily in Medical, Health Care and Biotechnology startups, most often at Funding Round and Series B stage. Most of the 7 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Alpenroute Asset Management?

Public channels for Alpenroute Asset Management include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Alpenroute Asset Management?

The team at Alpenroute Asset Management includes Hang-Ki Kim (CEO& Head of Fund Management). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Alpenroute Asset Management Alpenroute Asset Management Find emails